Events

11/17/2020

High-Throughput SARS-CoV-2 Detection with Custom Saliva-Based Collection Protocol

High-Throughput SARS-CoV-2 Detection with Custom Saliva-Based Collection Protocol

Join our webinar on November 12 to learn how Kashi Clinical Laboratories has quickly operationalized a custom saliva SARS-CoV-2 testing protocol by leveraging the BGI/MGI’s clinical lab partnership program. Featured speakers are Dr. Zahra Kashi (CEO/Founder) and Mrs. Dena Balbach (Chief Business Officer).

They will discuss an advanced approach that has enabled their high-complexity genetic testing laboratory to operationalize in COVID-19 molecular testing within weeks and the continued innovations that are required to help combat the deadly novel coronavirus.

Their discussions will also include:

  • Adoption of automation that enabled high-throughput, accurate testing
  • How they implemented a saliva-based collection protocol – the game changer for pathogen surveillance testing
  • Direct-to-consumer saliva testing – the next step to extend community coverage
  • Expansion of testing capacity through pooled samples
  • Partnership roles contributed by BGI and MGI

 

Click here to watch the webinar

Share with your community
Quick Contact